SoftSeal-STF Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.05M
SoftSeal-STF General Information
Description
Operator of a medical device company intended to develop next-generation proprietary hemostatic products. The company's hemostatic pad is biodegradable and biocompatible promotes the formation of a strong, stable clot, reduces the duration and amount of compression required, promotes early ambulation, and adheres to bleeding tissues, enabling doctors to help in controlling bleeding after an injury.
Contact Information
Website
chitogen.comCorporate Office
- 12805 Highway 55
- Suite 202
- Plymouth, MN 55441
- United States
Corporate Office
- 12805 Highway 55
- Suite 202
- Plymouth, MN 55441
- United States
SoftSeal-STF Timeline
SoftSeal-STF Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 13-Dec-2023 | $1.05M | Completed | Generating Revenue | ||
| 7. Later Stage VC | 15-Dec-2022 | Cancelled | Generating Revenue | |||
| 6. Later Stage VC | 06-May-2022 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 29-May-2015 | Completed | Generating Revenue | |||
| 4. Seed Round | 01-Jul-2014 | Completed | Generating Revenue | |||
| 3. Angel (individual) | 20-Mar-2013 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 21-Jan-2009 | $55K | Completed | Generating Revenue | ||
| 1. Angel (individual) | 01-Jul-2008 | $55K | $55K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
SoftSeal-STF Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
SoftSeal-STF Patents
SoftSeal-STF Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200405907-A1 | Stable and robust blended hemostatic composition | Active | 30-Jun-2019 | ||
| US-11027041-B2 | Stable and robust blended hemostatic composition | Active | 30-Jun-2019 | ||
| US-20160168276-A1 | Process for the removal of endotoxins to produce medical quality chitosan and other polysaccharides | Active | 16-Dec-2014 | ||
| US-9598504-B2 | Process for the removal of endotoxins to produce medical quality chitosan and other polysaccharides | Active | 16-Dec-2014 | ||
| US-10137219-B2 | Coherent blood coagulation structure of water-insoluble chitosan and water-dispersible starch coating | Active | 04-Aug-2014 | A61L15/28 |
SoftSeal-STF Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
SoftSeal-STF FAQs
-
When was SoftSeal-STF founded?
SoftSeal-STF was founded in 2007.
-
Where is SoftSeal-STF headquartered?
SoftSeal-STF is headquartered in Plymouth, MN.
-
What is the size of SoftSeal-STF?
SoftSeal-STF has 6 total employees.
-
What industry is SoftSeal-STF in?
SoftSeal-STF’s primary industry is Medical Supplies.
-
Is SoftSeal-STF a private or public company?
SoftSeal-STF is a Private company.
-
What is SoftSeal-STF’s current revenue?
The current revenue for SoftSeal-STF is .
-
How much funding has SoftSeal-STF raised over time?
SoftSeal-STF has raised $3.32M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
